IKT — Inhibikase Therapeutics, Inc.

IKTInhibikase Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · inhibikase.com

1.700USD+0.59%Mkt Cap: 224.46M USDP/E: —Last update: 2026-05-26

Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics to modify the course of cardiopulmonary diseases, with a primary focus on pulmonary arterial hypertension (PAH)…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

39.41BUSDP/E 74.0

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap224.46M USD

Enterprise Value126.17M USD

Revenue (TTM)—

Gross Profit1.01M USD

Net Income (TTM)-48.26M USD

Revenue/Share—

Last Price1.700 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees35

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS45719W1062

Valuation

P/E (Trailing)—

P/E (Forward)-4.58

PEG—

EV/EBITDA-2.61

EV/Revenue—

P/S—

P/B1.71

EPS (TTM)-0.44

EPS (Forward)-0.38

52W Range

1.33040% of range2.260

52W High2.260 USD

52W Low1.330 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-27.91%

ROA-26.63%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-27.79M USD

CapEx (TTM)452.02K USD

FCF Margin—

FCF Yield-6.67%

Net Debt-170.37M USD

Net Debt/EBITDA3.52

Balance Sheet

Debt/Equity0.00

Current Ratio30.14

Quick Ratio29.83

Book Value/Sh1.017 USD

Cash/Share1.000 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:6

Split DateJun 30, 2023

Analyst Consensus

Rating1.1 (Strong Buy)

Target (Mean)6.000 USD

Target Range3.000 USD – 8.000 USD

# Analysts7

Ownership

Shares Out.132.03M

Float86.88M

Insiders6.42%

Institutions93.30%

Short Interest

Short Ratio18.3d

Short % Float21.90%

Short % Out.13.62%

Shares Short17.98M

Short (prev mo.)17.26M

Technical

SMA 501.809 (-6.0%)

SMA 2001.703 (-0.2%)

Beta0.96

S&P 52W Chg28.31%

Avg Vol (30d)904.06K

Avg Vol (10d)881.92K

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—